LHCTX Mutual Fund (Lord Abbett Health Care Fund Class R5) is managed by Lord Abbett Family of Funds. LHCTX expense ratio is 0.78%, holding 61 positions across sectors including Health Care, Unknown, Other. Inception date: 2019-07-31.

LHCTX performance shows a YTD return of 4.71%. The 1-year return is 27.63% and the 5-year return is 5.89%. LHCTX dividend yield stands at 0.36%, paid annually.

LHCTX top holdings include Eli Lilly & Co (9.2%), Gilead Sciences Inc (4.3%), Toucan Finco Ltd./Toucan Finco Can, Inc./Toucan Finco U.S. Llc 8.25% 05/15/2030 (4.1%), AstraZeneca PLC (4.0%), argenx SE (3.9%). View all LHCTX holdings, sector breakdown, or dividend history.

LHCTX can be compared against other funds using the overlap calculator or side-by-side comparison tool. LHCTX alternatives are available via the screener, along with tax-loss harvesting opportunities.